Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2002-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(02)00127-4PMID 12213349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

  2002cited by this paper
• Tandem repeat of C/EBP binding sites mediates PPARγ2 gene transcription in glucocorticoid‐induced adipocyte differentiation

  2000cited by this paper
• Free fatty acids, insulin resistance, and type 2 diabetes mellitus.

  1999cited by this paper
• Glucocorticoids and insulin resistance: old hormones, new targets.

  1999cited by this paper
• Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.

  1999cited by this paper
• Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.

  1999cited by this paper
• Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.

  1999cited by this paper
• Thiazolidinediones: a new class of antidiabetic drugs

  1999influential reference
• Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.

  1999cited by this paper
• Peripheral insulin sensitivity is decreased by elevated non-esterified fatty acid level in dexamethasone-treated rats.

  1999cited by this paper
• PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

  1998cited by this paper
• Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes

  1998cited by this paper
• Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

  1998cited by this paper
• The biology of leptin: a review.

  1998cited by this paper
• Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.

  1998cited by this paper
• Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

  1998cited by this paper
• Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.

  1998cited by this paper
• Effects of troglitazone on dexamethasone-induced insulin resistance in rats.

  1998cited by this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cited by this paper
• Troglitazone action is independent of adipose tissue.

  1997cited by this paper
• Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

  1997cited by this paper
• Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

  1997cited by this paper
• Muscle Rad Expression and Human Metabolism: Potential Role of the Novel Ras-Related GTPase in Energy Expenditure and Body Composition

  1997cited by this paper
• Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome *

  1997cited by this paper
• Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

  1997cited by this paper
• Effect of Troglitazone on Leptin Production: Studies In Vitro and in Human Subjects

  1996cited by this paper
• Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm (*)

  1996cited by this paper
• Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans.

  1996cited by this paper
• Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism.

  1995cited by this paper
• Induction of ob Gene Expression by Corticosteroids Is Accompanied by Body Weight Loss and Reduced Food Intake (*)

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Thiazolidinediones are novel insulin-sensitizing agents

  1995cited by this paper
• Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome.

  1995cited by this paper
• Glucocorticoid-Induced Insulin Resistance: Dexamethasone Inhibits the Activation of Glucose Transport in Rat Skeletal Muscle by Both Insulin- and Non-Insulin-Related Stimuli

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

  1994cited by this paper
• Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.

  1993cited by this paper
• The effects of cortisol on insulin sensitivity in muscle.

  1992cited by this paper
• Effects of glucocorticoids on carbohydrate metabolism.

  1988cited by this paper
• An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.

  1983cited by this paper
• Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

  1982cited by this paper
• Modified colorimetric ultramicro method for estimating Nefa in serum

  1968cited by this paper
• [Free fatty acids].

  1967cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6- Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Revers

  year unknowncited by this paper

• Glucocorticoid-Induced Hyperglycemia in Patients with Cancer: Mechanisms, Clinical Implications, and Management Strategies.

  2026cites this paper
• Is It Time for a New Algorithm for the Pharmacotherapy of Steroid-Induced Diabetes?

  2024cites this paper
• Glucocorticoid-Induced Hyperglycemia: A Neglected Problem

  2024cites this paper
• Glucocorticoid-induced hyperglycemia and diabetes: practical points.

  2023cites this paper
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

  2023cites this paper
• Steroid Induced Diabetes Mellitus

  2023cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia

  2022cites this paper
• Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions

  2022cites this paper
• A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital

  2021cites this paper
• Diagnosis and Management Considerations in Steroid-Related Hyperglycemia in COVID-19: A Position Statement from the Endocrine Society of India

  2021cites this paper
• A new mouse model of type 2 diabetes mellitus established through combination of high-fat-diet, streptozotocin and glucocorticoid.

  2021cites this paper
• Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting

  2021cites this paper
• How should rheumatologists manage glucocorticoid-induced hyperglycemia?

  2020cites this paper
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION

  2019cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia

  2018cites this paper
• Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group

  2018cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia.

  2018cites this paper
• Optimizing the Treatment of Steroid-Induced Hyperglycemia

  2018cites this paper
• Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review.

  2018cites this paper
• Management of Glucocorticoid‐Induced Diabetes and/or Hyperglycemia

  2018cites this paper
• Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition

  2018cites this paper
• The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring

  2017cites this paper
• Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem

  2017cites this paper
• 15 hz Electroacupuncture at St36 Improves Insulin Sensitivity and Reduces Free Fatty Acid Levels in Rats with Chronic Dexamethasone-Induced Insulin Resistance

  2016cites this paper
• In‐Hospital Treatment and Surgery in People with Diabetes

  2016cites this paper
• Management of Steroid-induced Hyperglycemia

  2016cites this paper
• Role of Glia in Stress-Induced Enhancement and Impairment of Memory

  2016cites this paper
• Medication‐induced diabetes mellitus

  2016cites this paper
• [Management and Treatment of Glucocorticoid-Induced Hyperglycemia].

  2016cites this paper
• Effects of 6-Month Sitagliptin Treatment on Metabolic Parameters in Diabetic Patients Taking Oral Glucocorticoids: A Retrospective Cohort Study

  2015cites this paper
• The neuroenergetics of stress hormones in the hippocampus and implications for memory

  2015cites this paper
• Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review.

  2015cites this paper
• Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.

  2015cites this paper
• Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

  2014cites this paper
• Inpatient glucocorticoid use: beneficence vs non-maleficence.

  2014cites this paper
• From THE DEPARTMENT OF MOLECULAR MEDICINE AND SURGERY Karolinska Institutet, Stockholm, Sweden THE HPA AXIS IN TYPE 2 DIABETES SOME ASPECTS IN RELATION TO INSULIN SENSITIVITY, BETA-CELL FUNCTION AND IGF-I/IGFBP-1

  2014cites this paper
• Management of Acute and Late Endocrine Effects Following Childhood Cancer Treatment

  2013cites this paper
• Management of Diabetes and Hyperglycemia in Hospitalized Patients

  2013cites this paper
• Reversal of dexamethasone induced insulin resistance in 3T3L1 adipocytes by 3β-taraxerol of Mangifera indica.

  2013cites this paper
• Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients

  2012cites this paper
• Effects of Combination of Thiazolidinediones with Melatonin in Dexamethasone-induced Insulin Resistance in Mice

  2011cites this paper
• Exenatide improves glucocorticoid-induced glucose intolerance in mice

  2011cites this paper
• Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes.

  2010cites this paper
• Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.

  2010cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2010cites this paper
• More Survival Data Mining of Multiple Time of Endpoints

  2010cites this paper
• Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia.

  2009cites this paper
• blood pressure in adult patients with congenital adrenal

  2009cites this paper
• Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms.

  2009cites this paper
• Corticosteroid-induced Diabetes in Patients With Chronic Obstructive Pulmonary Disease: Brief Review

  2008cites this paper
• Diabetes mellitus post transplante

  2008cites this paper
• Diabetes management in the hospital.

  2008cites this paper
• Survival Data Mining: Treatment of Chronic Illness

  2008cites this paper
• Tratamiento de la diabetes en el hospital

  2008cites this paper
• Comprehensive management of post-transplant diabetes mellitus: from intensive care to home care.

  2007cites this paper
• The effects of fructose-1,6-bisphosphate and dexamethasone on acute inflammation and T-cell proliferation

  2006cites this paper
• Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.

  2005cites this paper
• Crocetin Prevents Dexamethasone-Induced Insulin Resistance in Rats

  2005cites this paper
• Rosiglitazone Therapy of Posttransplant Diabetes Mellitus

  2005cites this paper
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

  2005cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Glucocorticoids and insulin sensitivity in rheumatoid arthritis.

  2004cites this paper
• Inpatient management of diabetes and hyperglycemia.

  2004cites this paper
• Tolerancja glukozy w endokrynopatiach

  2004cites this paper
• Does altered glucocorticoid homeostasis increase cardiovascular risk?

  2004cites this paper
• Pioglitazone in the Management of Diabetes Mellitus after Transplantation

  2004influential citation
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Current literature in diabetes.

  2003cites this paper
• Current literature in diabetes

  2001cites this paper
• Bmc Complementary and Alternative Medicine Acute Effect of Electroacupuncture at the Zusanli Acupoints on Decreasing Insulin Resistance as Shown by Lowering Plasma Free Fatty Acid Levels in Steroid-background Male Rats

  year unknowncites this paper
• anu sc

  year unknowncites this paper